ARTICLE | Clinical News
Revlimid lenalidomide regulatory update
September 13, 2010 7:00 AM UTC
Celgene received a Paragraph IV certification letter indicating that Nacto Pharma Ltd. (Hyderabad, India) submitted an ANDA to FDA for a generic version of lenalidomide. Celgene said it plans to file ...